HEADER TRANSFERASE 14-AUG-08 3E64 TITLE FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 839 TO 1131); COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PFASBAC KEYWDS DRUG DISCOVERY, JAK2, FRAGMENT BASED, ATP-BINDING, DISEASE MUTATION, KEYWDS 2 KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO- KEYWDS 3 ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.ANTONYSAMY,W.FANG,G.HIRST,F.PARK,M.RUSSELL,L.SMYTH,P.SPRENGELER, AUTHOR 2 F.STAPPENBECK,R.STEENSMA,D.A.THOMPSON,M.WILSON,M.WONG,A.ZHANG, AUTHOR 3 F.ZHANG REVDAT 6 08-FEB-12 3E64 1 AUTHOR REVDAT 5 01-FEB-12 3E64 1 VERSN AUTHOR SOURCE REVDAT 4 09-JUN-09 3E64 1 REVDAT REVDAT 3 24-FEB-09 3E64 1 VERSN REVDAT 2 06-JAN-09 3E64 1 JRNL REVDAT 1 14-OCT-08 3E64 0 JRNL AUTH S.ANTONYSAMY,G.HIRST,F.PARK,P.SPRENGELER,F.STAPPENBECK, JRNL AUTH 2 R.STEENSMA,M.WILSON,M.WONG JRNL TITL FRAGMENT-BASED DISCOVERY OF JAK-2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 279 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19019674 JRNL DOI 10.1016/J.BMCL.2008.08.064 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC5 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30825 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2400 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 338 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3E64 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-08. REMARK 100 THE RCSB ID CODE IS RCSB048922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5-6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91998 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30826 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 24.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28-32% PEG 4000, 100 MM SODIUM CITRATE REMARK 280 PH 6.5-6.8, 200MM AMMONIUM ACETATE, PH 6.7, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.06000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.06000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.72150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.56050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.72150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.56050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.06000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.72150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 51.56050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 34.06000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.72150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 51.56050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 288 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 291 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 839 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 846 CG CD OE1 OE2 REMARK 470 ASN A 859 CG OD1 ND2 REMARK 470 PHE A 860 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 947 CD NE CZ NH1 NH2 REMARK 470 GLN A1003 CG CD OE1 NE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 860 -65.46 72.57 REMARK 500 SER A 887 66.68 -105.40 REMARK 500 LYS A 945 -133.88 47.44 REMARK 500 ARG A 975 -2.15 66.18 REMARK 500 ASP A 976 26.80 -142.87 REMARK 500 TRP A1106 47.35 -88.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5B3 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3E62 RELATED DB: PDB REMARK 900 RELATED ID: 3E63 RELATED DB: PDB DBREF 3E64 A 839 1131 UNP O60674 JAK2_HUMAN 839 1131 SEQRES 1 A 293 ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS PHE SEQRES 2 A 293 LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL GLU SEQRES 3 A 293 MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY GLU SEQRES 4 A 293 VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU GLU SEQRES 5 A 293 HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SEQRES 6 A 293 SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL SEQRES 7 A 293 CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE MET SEQRES 8 A 293 GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU GLN SEQRES 9 A 293 LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN SEQRES 10 A 293 TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY SEQRES 11 A 293 THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG ASN SEQRES 12 A 293 ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP SEQRES 13 A 293 PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU PTR SEQRES 14 A 293 PTR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE TRP SEQRES 15 A 293 TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER VAL SEQRES 16 A 293 ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU SEQRES 17 A 293 LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO ALA SEQRES 18 A 293 GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY GLN SEQRES 19 A 293 MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN ASN SEQRES 20 A 293 GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE SEQRES 21 A 293 TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL ASN SEQRES 22 A 293 GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL ASP SEQRES 23 A 293 GLN ILE ARG ASP ASN MET ALA MODRES 3E64 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 3E64 PTR A 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET 5B3 A 1 24 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 5B3 4-(3-AMINO-1H-INDAZOL-5-YL)-N-TERT- HETNAM 2 5B3 BUTYLBENZENESULFONAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 5B3 C17 H20 N4 O2 S FORMUL 3 HOH *338(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 936 LYS A 945 1 10 HELIX 4 4 GLU A 946 ILE A 948 5 3 HELIX 5 5 ASP A 949 LYS A 970 1 22 HELIX 6 6 ALA A 978 ARG A 980 5 3 HELIX 7 7 PRO A 1017 TYR A 1021 5 5 HELIX 8 8 ALA A 1022 SER A 1029 1 8 HELIX 9 9 SER A 1032 THR A 1049 1 18 HELIX 10 10 GLU A 1052 LYS A 1055 5 4 HELIX 11 11 SER A 1056 GLY A 1066 1 11 HELIX 12 12 GLY A 1071 ASN A 1084 1 14 HELIX 13 13 PRO A 1095 TRP A 1106 1 12 HELIX 14 14 ASN A 1109 ARG A 1113 5 5 HELIX 15 15 SER A 1115 ALA A 1131 1 17 SHEET 1 A 5 LEU A 849 LYS A 857 0 SHEET 2 A 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 A 5 LEU A 925 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 A 5 TYR A 913 TYR A 918 -1 N LYS A 914 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1008 LYS A1009 0 SHEET 2 D 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 SITE 1 AC1 11 HOH A 54 HOH A 211 GLY A 861 ALA A 880 SITE 2 AC1 11 GLU A 930 TYR A 931 LEU A 932 ASN A 981 SITE 3 AC1 11 LEU A 983 GLY A 993 ASP A 994 CRYST1 93.443 103.121 68.120 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010702 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014680 0.00000